gemcitabine,cisplatin,carboplatin,enfortumab,pembrolizumab
astellas,seagen,merck
[' cis ', 'pembro', 'ev103']
phenomenal presentation by my friend, the brilliant #asco23 results from #ev103: ev + pembro showing promising activity and tolerable safety profile in 1l cis ineligible #muc
beautiful tail for dor and os curves! 
Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow